Yili Xu

Yili Xu

Auto-generated profile, based on publicly available information

Yili Xu

Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
JSJiayi Shen
Jiayi Shen
ARAlex A. Rodriguez
Alex A. Rodriguez
ESEdward J. Saunders
Edward J. Saunders
FCFei Chen
Fei Chen
CHChristopher A. Haiman
Christopher A. Haiman

26 August 2022 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
YXYili Xu
Yili Xu
Yao YuYao Yu
Yao Yu
KNKevin T Nead
Kevin T Nead
TKTaeBeom Kim
TaeBeom Kim
BDBurcu F Darst
Burcu F Darst
Little is known regarding the potential relationship between clonal hematopoiesis (CH) of indeterminate potential (CHIP), which is the expansion of hematopoietic stem cells with somatic mutations, and risk of prostate cancer, the fifth leading cause of cancer death of men worldwide. We evaluated the association of age-related CHIP with overall and aggressive prostate cancer risk in two large whole-exome sequencing studies of 75 047 European ancestry men, including 7663 prostate cancer cases, 2770 of which had aggressive disease, and 3266 men carrying CHIP variants. We found that CHIP, defined by over 50 CHIP genes individually and in aggregate, was not significantly associated with overall (aggregate HR = 0.93, 95% CI = 0.76–1.13, P = 0.46) or aggressive (aggregate OR = 1.14, 95% CI = 0.92–1.41, P = 0.22) prostate cancer risk. CHIP was weakly associated with genetic risk of overall prostate cancer, measured using a polygenic risk score (OR = 1.05 per unit increase, 95% CI = 1.01–1.10, P = 0.01). CHIP was not significantly associated with carrying pathogenic/likely pathogenic/deleterious variants in DNA repair genes, which have previously been found to be associated with aggressive prostate cancer. While findings from this study suggest that CHIP is likely not a risk factor for prostate cancer, it will be important to investigate other types of CH in association with prostate cancer risk.

25 August 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
MLM. Kathryn Leonard
M. Kathryn Leonard
GPGemma S. Puts
Gemma S. Puts
NPNidhi Pamidimukkala
Nidhi Pamidimukkala
GAGautam Adhikary
Gautam Adhikary
YXYili Xu
Yili Xu
DKDavid Kaetzel
David Kaetzel

6 April 2022 in Cancer Causes & Control
Verified
Journal Article
Open access
PDF file
SHShawn M. Hercules
Shawn M. Hercules
XLXiyu Liu
Xiyu Liu
BBBlessing B. I. Bassey-Archibong
Blessing B. I. Bassey-Archibong
DSDesiree H. A. Skeete
Desiree H. A. Skeete
SCSuzanne Smith Connell
Suzanne Smith Connell
JDJuliet Daniel
Juliet Daniel
Purpose: Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype that disproportionately affects women of African ancestry (WAA) and is often associated with poor survival. Although there is a high prevalence of TNBC across West Africa and in women of the African diaspora, there has been no comprehensive genomics study to investigate the mutational profile of ancestrally related women across the Caribbean and West Africa.Methods: This multisite cross-sectional study used 31 formalin-fixed paraffin-embedded (FFPE) samples from Barbadian and Nigerian TNBC participants. High-resolution whole exome sequencing (WES) was performed on the Barbadian and Nigerian TNBC samples to identify their mutational profiles and comparisons were made to African American, European American and Asian American sequencing data obtained from The Cancer Genome Atlas (TCGA). Whole exome sequencing was conducted on tumors with an average of 382 × coverage and 4335 × coverage for pooled germline non-tumor samples.Results: Variants detected at high frequency in our WAA cohorts were found in the following genesNBPF12,PLIN4,TP53andBRCA1. In the TCGA TNBC cases, these genes had a lower mutation rate, except forTP53(32% in our cohort; 63% in TCGA-African American; 67% in TCGA-European American; 63% in TCGA-Asian). For all altered genes, there were no differences in frequency of mutations between WAA TNBC groups including the TCGA-African American cohort. For copy number variants, high frequency alterations were observed inPIK3CA, TP53, FGFR2andHIF1ANgenes.Conclusion: This study provides novel insights into the underlying genomic alterations in WAA TNBC samples and shines light on the importance of inclusion of under-represented populations in cancer genomics and biomarker studies.

7 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
ZMZarko Manojlovic
Zarko Manojlovic
AAAllyn Auslander
Allyn Auslander
YJYuxin Jin
Yuxin Jin
RSRyan J. Schmidt
Ryan J. Schmidt
YXYili Xu
Yili Xu
WIWilliam Magee Iii
William Magee Iii
Background: Orofacial clefts (OFCs) are common congenital disabilities that can occur as isolated non-syndromic events or as part of Mendelian syndromes. OFC risk factors vary due to differences in regional environmental exposures, genetic variants, and ethnicities. In recent years, significant progress has been made in understanding OFCs, due to advances in sequencing and genotyping technologies. Despite these advances, very little is known about the genetic interplay in the Malagasy population. Methods: Here, we performed high-resolution whole-exome sequencing (WES) on non-syndromic cleft lip with or without palate (nCL/P) trios in the Malagasy population (78 individuals from 26 families (trios)). To integrate the impact of genetic ancestry admixture, we computed both global and local ancestries. Results: Participants demonstrated a high percentage of both African and Asian admixture. We identified damaging variants in primary cilium-mediated pathway genes WNT5B (one family), GPC4 (one family), co-occurrence in MSX1 (five families), WDR11 (one family), and tubulin stabilizer SEPTIN9 (one family). Furthermore, we identified an autosomal homozygous damaging variant in PHGDH (one family) gene that may impact metabiotic activity. Lastly, all variants were predicted to reside on local Asian genetic ancestry admixed alleles. Conclusion: Our results from examining the Malagasy genome provide limited support for the hypothesis that germline variants in primary cilia may be risk factors for nCL/P, and outline the importance of integrating local ancestry components better to understand the multi-ethnic impact on nCL/P.

11 October 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
MLM. Kathryn Leonard
M. Kathryn Leonard
GPGemma S. Puts
Gemma S. Puts
NPNidhi Pamidimukkala
Nidhi Pamidimukkala
GAGautam Adhikary
Gautam Adhikary
YXYili Xu
Yili Xu
DKDavid Kaetzel
David Kaetzel